Cambridge, MA · Founded 2019 · Privately Held (backing)
Developer of a genome-wide cell programming platform designed to convert patient-derived stem cells into multiple cell types. GC Therapeutics is based in Cambridge, MA and was founded in 2019. Its last known valuation is $135 million. It has raised $74.7 million.
Last price · $/share
—
Implied valuation
$135.0M
Total raised
$74.7M
Last round
—
Team — not yet on record
No current team members for GC Therapeutics are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of GC Therapeutics with a free account
·The complete investor list: 14 names
·Watch GC Therapeutics: the Monday email on marks, rounds and moves
